Click HERE to download the PDF version

Servier Group is very well known as a world wide pharma player, but you recently have launched Servier CDMO. Can you tell our readers the reason that led to this business differentiation? 

We do not intend to compete with the biggest players of the CDMO space, but we have some competitive advantages that can differentiate us. There is a real demand for high-quality, reliable, flexible CDMOs. The business unit “Servier CDMO” was created to meet this market need, leveraging the expertise gained through 60 years of drug substance and drug product development and manufacturing, in combination with financial stability and a positive quality record. To meet current expectations for optimal CDMO services, we also focused on increasing the efficiency and flexibility across our 11 production sites, optimizing our industrial footprint, and developing unique deal structuring options and responsive communications.

Which is the most important aspect that players in this industry have to consi ... ...